Usual ACE Inhibitor Therapy in CKD Patients Is Associated with Lower Plasma Aldosterone Levels than Usual Angiotensin Receptor Blocker Therapy

Publisher： Karger

E-ISSN： 1423-0143|30|5|299-305

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.30, Iss.5, 2007-07, pp. : 299-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy

By  

American Journal of Nephrology, Vol. 19, Iss. 1, 1999-03 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Effect of Angiotensin II Receptor Blocker on Plasma Levels of TGF-β1 and Interstitial Fibrosis in Hypertensive Kidney Transplant Patients

By  

American Journal of Nephrology, Vol. 23, Iss. 5, 2003-09 ,pp. : 300-306

Karger

Access to resources Recommend Favorite

Impact of Angiotensin II Receptor Blocker on Plasma Levels of Adiponectin and Advanced Oxidation Protein Products in Peritoneal Dialysis Patients

By  

Blood Purification, Vol. 24, Iss. 5-6, 2006-12 ,pp. : 445-450

Karger

Access to resources Recommend Favorite

Safety and Tolerability of High-Dose Angiotensin Receptor Blocker Therapy in Patients with Chronic Kidney Disease: A Pilot Study

By  

American Journal of Nephrology, Vol. 24, Iss. 3, 2004-07 ,pp. : 340-345

Karger

Access to resources Recommend Favorite

Direct Renin Inhibitor is Better than Angiotensin II Receptor Blocker for Intrarenal Arterioles

By  

Kidney and Blood Pressure Research, Vol. 41, Iss. 5, 2016-08 ,pp. : 561-569

Karger

Access to resources Recommend Favorite